Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAMTS5 | Q9UNA0 | 19/20 | 0.52 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.52 |
| ▸ | MMP13 | P45452 | 3/20 | 0.51 |
| ▸ | MMP2 | P08253 | 5/20 | 0.49 |
| ▸ | ADAMTS4 | O75173 | 2/20 | 0.49 |
| ▸ | MMP14 | P50281 | 1/20 | 0.49 |
| ▸ | ADAMTS1 | Q9UHI8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23745235 | 1.00 | ADAMTS5 (0.52) | ADAMTS5ADAM17MMP13MMP2ADAMTS4 | |
| SCHEMBL23745294 | 0.89 | ADAMTS5 (0.56) | ADAMTS5ADAM17MMP13MMP2ADAMTS4 | |
| SCHEMBL29116575 | 0.88 | ADAMTS5 (0.56) | ADAMTS5ADAM17MMP13MMP2ADAMTS4 | |
| SCHEMBL23745400 | 0.88 | ADAMTS5 (0.56) | ADAMTS5ADAM17MMP13MMP2ADAMTS4 | |
| SCHEMBL29835119 | 0.86 | ADAMTS5 (0.49) | ADAMTS5ADAM17MMP13MMP2ADAMTS4 | |
| SCHEMBL29250261 | 0.86 | ADAMTS5 (0.49) | ADAMTS5ADAM17MMP13MMP2ADAMTS4 | |
| SCHEMBL23745258 | 0.86 | ADAMTS5 (0.49) | ADAMTS5ADAM17MMP13MMP2ADAMTS4 | |
| SCHEMBL23745214 | 0.84 | ADAMTS5 (0.55) | ADAMTS5ADAM17MMP13MMP2ADAMTS4 | |
| SCHEMBL29835134 | 0.84 | ADAMTS5 (0.55) | ADAMTS5ADAM17MMP13MMP2ADAMTS4 | |
| SCHEMBL29250257 | 0.84 | ADAMTS5 (0.55) | ADAMTS5ADAM17MMP13MMP2ADAMTS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115052596-B | ADAMTS inhibitor, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2024-06-14 | — | — | CN | disclosed |